INO icon

Inovio Pharmaceuticals
INO

Overview Fund Activity

213 hedge funds and large institutions have $555M invested in Inovio Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 60 reducing their positions, and 26 closing their positions.

Holders
213
Holders Change
+2
Holders Change %
+0.95%
% of All Funds
3.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
33
Increased
58
Reduced
60
Closed
26
Calls
$25.6M
Puts
$32.5M
Net Calls
-$6.89M
Net Calls Change
-$3.61M

Top Buyers

1
State Street
1
State Street
Massachusetts
$78.4M
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$27.2M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$29.4M
4
Goldman Sachs
4
Goldman Sachs
New York
$12.6M
5
UBS Group
5
UBS Group
Switzerland
$3.27M

Top Sellers

1
Nuveen Asset Management
1
Nuveen Asset Management
Illinois
$6.79M
2
Citadel Advisors
2
Citadel Advisors
Florida
$3.34M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$23.8M
4
Citigroup
4
Citigroup
New York
$2.67M
5
State of New Jersey Common Pension Fund D
5
State of New Jersey Common Pension Fund D
New Jersey
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
SOW
226
State of Wyoming
Wyoming
– -$3K -29 Closed
SGAM
227
Smith Group Asset Management
Texas
– -$2K -15 Closed
DWMG
228
DB Wealth Management Group
California
– -$1K -8 Closed
6 7 8 9
10